NCT03920527View on ClinicalTrials.gov

Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA

PHASE3CompletedINTERVENTIONAL

Enrollment

164

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

July 1, 2021

Study Completion Date

August 15, 2021

Conditions

Chronic Pulmonary Aspergillosis

Interventions

DRUG

Itraconazole 400 mg

Duration of itraconazole

Trial Locations (1)

160012

Inderpaul Singh, Chandigarh

All Listed Sponsors

lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT03920527 - Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA | Biotech Hunter | Biotech Hunter